Anxiety and Depression Treatment Market Insights, Global Outlook and Forecast 2022-2028
Anxiety and Depression Treatment Market Insights, Global Outlook and Forecast 2022-2028
Analysis of the Anxiety and Depression Treatment Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The latest research study released by Market IntelliX evaluates market size and forecasts of Anxiety and Depression Treatment in Global, including the following market information:
Global Anxiety and Depression Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anxiety and Depression Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anxiety Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anxiety and Depression Treatment include Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck, AbbVie, Eli Lilly and Company, GlaxoSmithKline and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Anxiety and Depression Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Anxiety and Depression Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anxiety and Depression Treatment Market Segment Percentages, by Type, 2021 (%)
Anxiety Drugs
Depression Drugs
Global Anxiety and Depression Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anxiety and Depression Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Pharmacy
Others
Global Anxiety and Depression Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anxiety and Depression Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anxiety and Depression Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anxiety and Depression Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Novartis AG
Pfizer Inc.
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
AbbVie
Eli Lilly and Company
GlaxoSmithKline
Sanofi
H. Lundbeck
Mylan
Cipla
Glenmark Life Sciences
Lupin Limited
Amneal Pharmaceuticals
AstraZeneca
Sun Pharmaceutical Industries Ltd.
Intas Pharmaceuticals
Sumitomo Dainippon Pharma
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Anxiety and Depression Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anxiety and Depression Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anxiety and Depression Treatment Overall Market Size
2.1 Global Anxiety and Depression Treatment Market Size: 2021 VS 2028
2.2 Global Anxiety and Depression Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anxiety and Depression Treatment Players in Global Market
3.2 Top Global Anxiety and Depression Treatment Companies Ranked by Revenue
3.3 Global Anxiety and Depression Treatment Revenue by Companies
3.4 Top 3 and Top 5 Anxiety and Depression Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anxiety and Depression Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anxiety and Depression Treatment Players in Global Market
3.6.1 List of Global Tier 1 Anxiety and Depression Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Anxiety and Depression Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anxiety and Depression Treatment Market Size Markets, 2021 & 2028
4.1.2 Anxiety Drugs
4.1.3 Depression Drugs
4.2 By Type - Global Anxiety and Depression Treatment Revenue & Forecasts
4.2.1 By Type - Global Anxiety and Depression Treatment Revenue, 2017-2022
4.2.2 By Type - Global Anxiety and Depression Treatment Revenue, 2023-2028
4.2.3 By Type - Global Anxiety and Depression Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anxiety and Depression Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Others
5.2 By Application - Global Anxiety and Depression Treatment Revenue & Forecasts
5.2.1 By Application - Global Anxiety and Depression Treatment Revenue, 2017-2022
5.2.2 By Application - Global Anxiety and Depression Treatment Revenue, 2023-2028
5.2.3 By Application - Global Anxiety and Depression Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Anxiety and Depression Treatment Market Size, 2021 & 2028
6.2 By Region - Global Anxiety and Depression Treatment Revenue & Forecasts
6.2.1 By Region - Global Anxiety and Depression Treatment Revenue, 2017-2022
6.2.2 By Region - Global Anxiety and Depression Treatment Revenue, 2023-2028
6.2.3 By Region - Global Anxiety and Depression Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Anxiety and Depression Treatment Revenue, 2017-2028
6.3.2 US Anxiety and Depression Treatment Market Size, 2017-2028
6.3.3 Canada Anxiety and Depression Treatment Market Size, 2017-2028
6.3.4 Mexico Anxiety and Depression Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Anxiety and Depression Treatment Revenue, 2017-2028
6.4.2 Germany Anxiety and Depression Treatment Market Size, 2017-2028
6.4.3 France Anxiety and Depression Treatment Market Size, 2017-2028
6.4.4 U.K. Anxiety and Depression Treatment Market Size, 2017-2028
6.4.5 Italy Anxiety and Depression Treatment Market Size, 2017-2028
6.4.6 Russia Anxiety and Depression Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Anxiety and Depression Treatment Market Size, 2017-2028
6.4.8 Benelux Anxiety and Depression Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Anxiety and Depression Treatment Revenue, 2017-2028
6.5.2 China Anxiety and Depression Treatment Market Size, 2017-2028
6.5.3 Japan Anxiety and Depression Treatment Market Size, 2017-2028
6.5.4 South Korea Anxiety and Depression Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Anxiety and Depression Treatment Market Size, 2017-2028
6.5.6 India Anxiety and Depression Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Anxiety and Depression Treatment Revenue, 2017-2028
6.6.2 Brazil Anxiety and Depression Treatment Market Size, 2017-2028
6.6.3 Argentina Anxiety and Depression Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anxiety and Depression Treatment Revenue, 2017-2028
6.7.2 Turkey Anxiety and Depression Treatment Market Size, 2017-2028
6.7.3 Israel Anxiety and Depression Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Anxiety and Depression Treatment Market Size, 2017-2028
6.7.5 UAE Anxiety and Depression Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Anxiety and Depression Treatment Major Product Offerings
7.1.4 Novartis AG Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Corporate Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Anxiety and Depression Treatment Major Product Offerings
7.2.4 Pfizer Inc. Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.2.5 Pfizer Inc. Key News
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Corporate Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Anxiety and Depression Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Company Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Company Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Anxiety and Depression Treatment Major Product Offerings
7.4.4 Johnson & Johnson Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Anxiety and Depression Treatment Major Product Offerings
7.5.4 Merck Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.5.5 Merck Key News
7.6 AbbVie
7.6.1 AbbVie Corporate Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Anxiety and Depression Treatment Major Product Offerings
7.6.4 AbbVie Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.6.5 AbbVie Key News
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Corporate Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Anxiety and Depression Treatment Major Product Offerings
7.7.4 Eli Lilly and Company Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.7.5 Eli Lilly and Company Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Anxiety and Depression Treatment Major Product Offerings
7.8.4 GlaxoSmithKline Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Anxiety and Depression Treatment Major Product Offerings
7.9.4 Sanofi Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.9.5 Sanofi Key News
7.10 H. Lundbeck
7.10.1 H. Lundbeck Corporate Summary
7.10.2 H. Lundbeck Business Overview
7.10.3 H. Lundbeck Anxiety and Depression Treatment Major Product Offerings
7.10.4 H. Lundbeck Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.10.5 H. Lundbeck Key News
7.11 Mylan
7.11.1 Mylan Corporate Summary
7.11.2 Mylan Business Overview
7.11.3 Mylan Anxiety and Depression Treatment Major Product Offerings
7.11.4 Mylan Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.11.5 Mylan Key News
7.12 Cipla
7.12.1 Cipla Corporate Summary
7.12.2 Cipla Business Overview
7.12.3 Cipla Anxiety and Depression Treatment Major Product Offerings
7.12.4 Cipla Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.12.5 Cipla Key News
7.13 Glenmark Life Sciences
7.13.1 Glenmark Life Sciences Corporate Summary
7.13.2 Glenmark Life Sciences Business Overview
7.13.3 Glenmark Life Sciences Anxiety and Depression Treatment Major Product Offerings
7.13.4 Glenmark Life Sciences Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.13.5 Glenmark Life Sciences Key News
7.14 Lupin Limited
7.14.1 Lupin Limited Corporate Summary
7.14.2 Lupin Limited Business Overview
7.14.3 Lupin Limited Anxiety and Depression Treatment Major Product Offerings
7.14.4 Lupin Limited Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.14.5 Lupin Limited Key News
7.15 Amneal Pharmaceuticals
7.15.1 Amneal Pharmaceuticals Corporate Summary
7.15.2 Amneal Pharmaceuticals Business Overview
7.15.3 Amneal Pharmaceuticals Anxiety and Depression Treatment Major Product Offerings
7.15.4 Amneal Pharmaceuticals Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.15.5 Amneal Pharmaceuticals Key News
7.16 AstraZeneca
7.16.1 AstraZeneca Corporate Summary
7.16.2 AstraZeneca Business Overview
7.16.3 AstraZeneca Anxiety and Depression Treatment Major Product Offerings
7.16.4 AstraZeneca Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.16.5 AstraZeneca Key News
7.17 Sun Pharmaceutical Industries Ltd.
7.17.1 Sun Pharmaceutical Industries Ltd. Corporate Summary
7.17.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.17.3 Sun Pharmaceutical Industries Ltd. Anxiety and Depression Treatment Major Product Offerings
7.17.4 Sun Pharmaceutical Industries Ltd. Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.17.5 Sun Pharmaceutical Industries Ltd. Key News
7.18 Intas Pharmaceuticals
7.18.1 Intas Pharmaceuticals Corporate Summary
7.18.2 Intas Pharmaceuticals Business Overview
7.18.3 Intas Pharmaceuticals Anxiety and Depression Treatment Major Product Offerings
7.18.4 Intas Pharmaceuticals Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.18.5 Intas Pharmaceuticals Key News
7.19 Sumitomo Dainippon Pharma
7.19.1 Sumitomo Dainippon Pharma Corporate Summary
7.19.2 Sumitomo Dainippon Pharma Business Overview
7.19.3 Sumitomo Dainippon Pharma Anxiety and Depression Treatment Major Product Offerings
7.19.4 Sumitomo Dainippon Pharma Anxiety and Depression Treatment Revenue in Global Market (2017-2022)
7.19.5 Sumitomo Dainippon Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Anxiety and Depression Treatment Market Opportunities & Trends in Global Market
Table 2. Anxiety and Depression Treatment Market Drivers in Global Market
Table 3. Anxiety and Depression Treatment Market Restraints in Global Market
Table 4. Key Players of Anxiety and Depression Treatment in Global Market
Table 5. Top Anxiety and Depression Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anxiety and Depression Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anxiety and Depression Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anxiety and Depression Treatment Product Type
Table 9. List of Global Tier 1 Anxiety and Depression Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anxiety and Depression Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anxiety and Depression Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anxiety and Depression Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anxiety and Depression Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anxiety and Depression Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anxiety and Depression Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anxiety and Depression Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anxiety and Depression Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anxiety and Depression Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anxiety and Depression Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anxiety and Depression Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anxiety and Depression Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anxiety and Depression Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anxiety and Depression Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anxiety and Depression Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Anxiety and Depression Treatment Product Offerings
Table 32. Novartis AG Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Inc. Corporate Summary
Table 34. Pfizer Inc. Anxiety and Depression Treatment Product Offerings
Table 35. Pfizer Inc. Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Company Corporate Summary
Table 37. Bristol-Myers Squibb Company Anxiety and Depression Treatment Product Offerings
Table 38. Bristol-Myers Squibb Company Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Anxiety and Depression Treatment Product Offerings
Table 41. Johnson & Johnson Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Anxiety and Depression Treatment Product Offerings
Table 44. Merck Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 45. AbbVie Corporate Summary
Table 46. AbbVie Anxiety and Depression Treatment Product Offerings
Table 47. AbbVie Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company Anxiety and Depression Treatment Product Offerings
Table 50. Eli Lilly and Company Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Anxiety and Depression Treatment Product Offerings
Table 53. GlaxoSmithKline Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Anxiety and Depression Treatment Product Offerings
Table 56. Sanofi Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 57. H. Lundbeck Corporate Summary
Table 58. H. Lundbeck Anxiety and Depression Treatment Product Offerings
Table 59. H. Lundbeck Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Mylan Corporate Summary
Table 61. Mylan Anxiety and Depression Treatment Product Offerings
Table 62. Mylan Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Cipla Corporate Summary
Table 64. Cipla Anxiety and Depression Treatment Product Offerings
Table 65. Cipla Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Glenmark Life Sciences Corporate Summary
Table 67. Glenmark Life Sciences Anxiety and Depression Treatment Product Offerings
Table 68. Glenmark Life Sciences Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Lupin Limited Corporate Summary
Table 70. Lupin Limited Anxiety and Depression Treatment Product Offerings
Table 71. Lupin Limited Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Amneal Pharmaceuticals Corporate Summary
Table 73. Amneal Pharmaceuticals Anxiety and Depression Treatment Product Offerings
Table 74. Amneal Pharmaceuticals Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 75. AstraZeneca Corporate Summary
Table 76. AstraZeneca Anxiety and Depression Treatment Product Offerings
Table 77. AstraZeneca Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Sun Pharmaceutical Industries Ltd. Corporate Summary
Table 79. Sun Pharmaceutical Industries Ltd. Anxiety and Depression Treatment Product Offerings
Table 80. Sun Pharmaceutical Industries Ltd. Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Intas Pharmaceuticals Corporate Summary
Table 82. Intas Pharmaceuticals Anxiety and Depression Treatment Product Offerings
Table 83. Intas Pharmaceuticals Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Sumitomo Dainippon Pharma Corporate Summary
Table 85. Sumitomo Dainippon Pharma Anxiety and Depression Treatment Product Offerings
Table 86. Sumitomo Dainippon Pharma Anxiety and Depression Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Anxiety and Depression Treatment Segment by Type in 2021
Figure 2. Anxiety and Depression Treatment Segment by Application in 2021
Figure 3. Global Anxiety and Depression Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anxiety and Depression Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anxiety and Depression Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anxiety and Depression Treatment Revenue in 2021
Figure 8. By Type - Global Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 12. US Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 24. China Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anxiety and Depression Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anxiety and Depression Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Inc. Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Company Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AbbVie Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly and Company Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sanofi Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. H. Lundbeck Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Mylan Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cipla Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Glenmark Life Sciences Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Lupin Limited Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Amneal Pharmaceuticals Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. AstraZeneca Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Sun Pharmaceutical Industries Ltd. Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Intas Pharmaceuticals Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Sumitomo Dainippon Pharma Anxiety and Depression Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Research Methodology:
Anxiety and Depression Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|